Physician profile
Mitchell Andrew Pullias
NPI 1215926860
$516.87
in general payments reported to CMS, 2019-2025
12 companies · $102 in 2025
The $102 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.56 · 2020: $12.73 · 2021: $118 · 2022: $89.01 · 2023: $75.49 · 2024: $108 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $88.45 | 2023-2025 | |
| Abbvie INC. | $82.47 | 2021-2025 | |
| Novo Nordisk INC | $68.91 | 2019-2024 | Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $53.82 | 2023-2024 | Inspire |
| Astellas Pharma US INC | $47.90 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $41.75 | 2020-2021 | |
| Dexcom, INC. | $35.23 | 2021-2022 | |
| Glaxosmithkline, LLC. | $28.43 | 2022-2023 | Shingrix |
| Amarin Pharma, INC. | $19.82 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.76 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.72 | 2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Pullias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.